Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  401 نتائج ل ""Myelofibrosis""

فلترة النتائج

Subject : janus kinase 2
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Data-driven analysis of the kinetics of the JAK2V617F allele burden and blood cell counts during hydroxyurea treatment of patients with polycythemia vera, essential thrombocythemia, and primary myelofibrosis.

  • Authors : Dam MJB; Center for Mathematical Modeling - Human Health and Disease, IMFUFA, Department of Science and Environment, Roskilde University, Roskilde, Denmark.; Pedersen RK

Subjects: Alleles* ; Blood Cell Count*; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use

  • Source: European journal of haematology [Eur J Haematol] 2021 Dec; Vol. 107 (6), pp. 624-633. Date of Electronic Publication: 2021 Sep 30.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Adherence to ruxolitinib, an oral JAK1/2 inhibitor, in patients with myelofibrosis: interim analysis from an Italian, prospective cohort study (ROMEI).

Subjects: Janus Kinase 1*/Janus Kinase 1*/Janus Kinase 1*/antagonists & inhibitors ; Janus Kinase 2*/Janus Kinase 2*/Janus Kinase 2*/antagonists & inhibitors ; Primary Myelofibrosis*/Primary Myelofibrosis*/Primary Myelofibrosis*/drug therapy

  • Source: Leukemia & lymphoma [Leuk Lymphoma] 2022 Jan; Vol. 63 (1), pp. 189-198. Date of Electronic Publication: 2021 Sep 15.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Effect of pre-transplant JAK1/2 inhibitors and CD34 dose on transplant outcomes in myelofibrosis.

  • Authors : Cyriac S; Hans Messner Allogeneic Blood and Marrow Transplantation Program, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.; Prem S

Subjects: Hematopoietic Stem Cell Transplantation*; Antigens, CD34/Antigens, CD34/Antigens, CD34/*immunology ; Janus Kinase 1/Janus Kinase 1/Janus Kinase 1/*antagonists & inhibitors

  • Source: European journal of haematology [Eur J Haematol] 2021 Nov; Vol. 107 (5), pp. 517-528. Date of Electronic Publication: 2021 Jul 27.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Immunoproteasome Genes Are Modulated in CD34 + JAK2 V617F Mutated Cells from Primary Myelofibrosis Patients.

  • Authors : Di Rosa M; Department of Biomedical and Biotechnological Sciences, Human Anatomy and Histology Section, School of Medicine, University of Catania, 95125 Catania, Italy.; Giallongo C

Subjects: Mutation*; Immunomodulation/Immunomodulation/Immunomodulation/*genetics ; Janus Kinase 2/Janus Kinase 2/Janus Kinase 2/*genetics

  • Source: International journal of molecular sciences [Int J Mol Sci] 2020 Apr 22; Vol. 21 (8). Date of Electronic Publication: 2020 Apr 22.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

A distinct molecular mutational profile and its clinical impact in essential thrombocythemia and primary myelofibrosis patients.

  • Authors : Zaidi U; Department of Clinical Hematology, National Institute of Blood Diseases & Bone Marrow Transplantation, Karachi, Pakistan. .; Sufaida G

Subjects: Calreticulin/Calreticulin/Calreticulin/*genetics ; DNA Mutational Analysis/DNA Mutational Analysis/DNA Mutational Analysis/*methods ; Janus Kinase 2/Janus Kinase 2/Janus Kinase 2/*genetics

  • Source: BMC cancer [BMC Cancer] 2020 Mar 12; Vol. 20 (1), pp. 205. Date of Electronic Publication: 2020 Mar 12.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Report

Progression of JAK2- mutant polycythemia vera to CALR -mutant myelofibrosis severely impacts on disease phenotype and response to therapy.

  • Authors : Holmström MO; Department of Hematology, Zealand University Hospital, Roskilde, Denmark.; National Center for Cancer Immune Therapy, Department of Hematology, Herlev University Hospital, Herlev, Denmark.

Subjects: Calreticulin/Calreticulin/Calreticulin/*genetics ; Janus Kinase 2/Janus Kinase 2/Janus Kinase 2/*genetics ; Polycythemia Vera/Polycythemia Vera/Polycythemia Vera/*genetics

  • Source: Leukemia & lymphoma [Leuk Lymphoma] 2019 Dec; Vol. 60 (13), pp. 3296-3299. Date of Electronic Publication: 2019 Jul 01.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

JAK2 rs10974944 is associated with both V617F-positive and negative myeloproliferative neoplasms in a Vietnamese population: A potential genetic marker.

  • Authors : Ngoc NT; Department of Life Sciences, University of Science and Technology of Hanoi, Vietnam Academy of Science and Technology, Hanoi, Vietnam.; Hau BB

Subjects: Janus Kinase 2*/Janus Kinase 2*/Janus Kinase 2*/genetics ; Myeloproliferative Disorders*/Myeloproliferative Disorders*/Myeloproliferative Disorders*/genetics ; Polycythemia Vera*/Polycythemia Vera*/Polycythemia Vera*/genetics

  • Source: Molecular genetics & genomic medicine [Mol Genet Genomic Med] 2022 Oct; Vol. 10 (10), pp. e2044. Date of Electronic Publication: 2022 Aug 22.Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101603758 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Report

Phase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosis.

  • Authors : Mascarenhas J; a Icahn School of Medicine at Mount Sinai , Tisch Cancer Institute , New York , NY , USA.; Baer MR

Subjects: Carbazoles/Carbazoles/Carbazoles/*therapeutic use ; Janus Kinase 2/Janus Kinase 2/Janus Kinase 2/*antagonists & inhibitors ; Janus Kinase Inhibitors/Janus Kinase Inhibitors/Janus Kinase Inhibitors/*therapeutic use

  • Source: Leukemia & lymphoma [Leuk Lymphoma] 2019 May; Vol. 60 (5), pp. 1343-1345. Date of Electronic Publication: 2019 Jan 22.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

JAK2, CALR, and MPL Mutation Profiles in Colombian patients with BCR-ABL Negative Myeloproliferative Neoplasms.

Subjects: Janus Kinase 2*/Janus Kinase 2*/Janus Kinase 2*/genetics ; Myeloproliferative Disorders*/Myeloproliferative Disorders*/Myeloproliferative Disorders*/genetics ; Myeloproliferative Disorders*/Myeloproliferative Disorders*/Myeloproliferative Disorders*/metabolism

  • Source: Colombia medica (Cali, Colombia) [Colomb Med (Cali)] 2023 Sep 30; Vol. 54 (3), pp. e2035353. Date of Electronic Publication: 2023 Sep 30 (Print Publication: 2023).Publisher: Universidad del Valle, Facultad de Salud Country of Publication: Colombia NLM ID: 9212578 Publication Model: eCollection Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

A case of double positive myeloproliferative neoplasm: A diagnostic and therapeutic challenge.

  • Authors : Shaikh AB; Department of Hematopathology, AmPath, Hyderabad, Telangana, India.; Aribandi A

Subjects: Fusion Proteins, bcr-abl/Fusion Proteins, bcr-abl/Fusion Proteins, bcr-abl/*genetics ; Janus Kinase 2/Janus Kinase 2/Janus Kinase 2/*genetics ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/Leukemia, Myelogenous, Chronic, BCR-ABL Positive/Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*genetics

  • Source: Indian journal of pathology & microbiology [Indian J Pathol Microbiol] 2021 Oct-Dec; Vol. 64 (4), pp. 820-823.Publisher: Medknow Country of Publication: India NLM ID: 7605904 Publication Model: Print Cited Medium: Internet ISSN: 0974-5130 (Electronic)

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  401 نتائج ل ""Myelofibrosis""